The Moderating Effect of Serum Vitamin D on the Relationship between Beta-amyloid Deposition and Neurodegeneration

키워드

참고문헌 (49)

1. Houston DK, "Vitamin D and age-related health outcomes : movement, mood, and memory", Curr Nutr Rep, 4, pp.185~200 (2015)
2. Veldurthy V, "Vitamin D, calcium homeostasis and aging", Bone Res, 4, pp.16041~ (2016)
3. Fleet JC, "The role of vitamin D in the endocrinology controlling calcium homeostasis", Mol Cell Endocrinol, 453, pp.36~45 (2017)
4. Berridge MJ, "Vitamin D cell signalling in health and disease", Biochem Biophys Res Commun, 460, pp.53~71 (2015)
5. Holick MF, "Vitamin D : a millenium perspective", J Cell Biochem, 88, pp.296~307 (2003)
6. Annweiler C, "Vitamin D and ageing : neurological issues", Neuropsychobiology, 62, pp.139~150 (2010)
7. Bikle D, "Nonclassic actions of vitamin D", J Clin Endocrinol Metab, 94, pp.26~34 (2009)
8. Llewellyn DJ, "Vitamin D and risk of cognitive decline in elderly persons", Arch Intern Med, 170, pp.1135~1141 (2010)
9. Slinin Y, "Association between serum 25(OH)vitamin D and the risk of cognitive decline in older women", J Gerontol A Biol Sci Med Sci, 67, pp.1092~1098 (2012)
10. Buell JS, "25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services", Neurology, 74, pp.18~26 (2010)
11. Littlejohns TJ, "Vitamin D and the risk of dementia and Alzheimer disease", Neurology, 83, pp.920~928 (2014)
12. Afzal S, "Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia", Alzheimers Dement, 10, pp.296~302 (2014)
13. Feart C, "Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer’s disease in older adults", Alzheimers Dement, 13, pp.1207~1216 (2017)
14. Jayedi A, "Vitamin D status and risk of dementia and Alzheimer’s disease : a meta-analysis of dose-response", Nutr Neurosci, 22, pp.750~759 (2019)
15. Chen H, "25-Hydroxyvitamin D Levels and the risk of dementia and Alzheimer’s disease : a dose-response meta-analysis", Front Aging Neurosci, 10, pp.368~ (2018)
16. Márquez F, "Neuroimaging biomarkers for Alzheimer’s disease", Mol Neurodegener, 14, pp.21~ (2019)
17. Hyman BT, "National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease", Alzheimers Dement, 8, pp.1~13 (2012)
18. Scheltens P, "Alzheimer’s disease", Lancet, 397, pp.1577~1590 (2021)
19. Jack CR Jr, "Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade", Lancet Neurol, 9, pp.119~128 (2010)
20. Grimm MO, "Impact of Vitamin D on amyloid precursor protein processing and amyloid-β peptide degradation in Alzheimer's disease", Neurodegener Dis, 13, pp.75~81 (2014)
21. Grimm MOW, "Vitamin D and Its Analogues Decrease Amyloid-β(Aβ)Formation and Increase Aβ-Degradation", Int J Mol Sci, 18, pp.2764~ (2017)
22. Ito S, "1α, 25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40)from mouse brain across the blood-brain barrier", Fluids Barriers CNS, 8, pp.20~ (2011)
23. Durk MR, "1α, 25-Dihydroxyvitamin D3 reduces cerebral amyloid-β accumulation and improves cognition in mouse models of Alzheimer's disease", J Neurosci, 34, pp.7091~7101 (2014)
24. Dursun E, "A new mechanism for amyloid-β induction of iNOS : vitamin D-VDR pathway disruption", J Alzheimers Dis, 36, pp.459~474 (2013)
25. Briones TL, "Vitamin D mitigates age-related cognitive decline through the modulation of pro-inflammatory state and decrease in amyloid burden", J Neuroinflammation, 9, pp.244~ (2012)
26. Nissou MF, "Additional clues for a protective role of vitamin D in neurodegenerative diseases : 1, 25-dihydroxyvitamin D3 triggers an anti-inflammatory response in brain pericytes", J Alzheimers Dis, 42, pp.789~799 (2014)
27. Fan YG, "Vitamin D deficiency exacerbates Alzheimer-like pathologies by reducing antioxidant capacity", Free Radic Biol Med, 161, pp.139~149 (2020)
28. Hooshmand B, "Vitamin D in relation to cognitive impairment, cerebrospinal fluid biomarkers, and brain volumes", J Gerontol A Biol Sci Med Sci, 69, pp.1132~1138 (2014)
29. Nourhashemi F, "Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia", Alzheimers Res Ther, 10, pp.43~ (2018)
30. Byun MS, "Korean brain aging study for the early diagnosis and prediction of Alzheimer’s disease : methodology and baseline sample characteristics", Psychiatry Investig, 14, pp.851~863 (2017)
31. Albert MS, "The diagnosis of mild cognitive impairment due to Alzheimer’s disease : recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.270~279 (2011)
32. Lee JH, "Development of the Korean version of the Consortium to Establish a Registry for Alzheimer’s Disease Assessment Packet(CERAD-K) : clinical and neuropsychological assessment batteries", J Gerontol B Psychol Sci Soc Sci, 57, pp.P47~P53 (2002)
33. Lee DY, "A normative study of the CERAD neuropsychological assessment battery in the Korean elderly", J Int Neuropsychol Soc, 10, pp.72~81 (2004)
34. DeCarli C, "Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia", Neurology, 63, pp.220~227 (2004)
35. Wenham PR, "Apolipoprotein E genotyping by one-stage PCR", Lancet, 337, pp.1158~1159 (1991)
36. Park JC, "Plasma tau", amyloid-β1-42 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease, 2019, pp.142, 771~786
37. Tzourio-Mazoyer N, "Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain", Neuroimage, 15, pp.273~289 (2002)
38. Reiman EM, "Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer’s disease", Proc Natl Acad Sci U S A, 106, pp.6820~6825 (2009)
39. Diedrichsen J, "Imaging the deep cerebellar nuclei : a probabilistic atlas and normalization procedure", Neuroimage, 54, pp.1786~1794 (2011)
40. Villeneuve S, "Existing Pittsburgh Compound-B positron emission tomography thresholds are too high : statistical and pathological evaluation", Brain, 138, pp.2020~2033 (2015)
41. Jack CR Jr, "Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years : a cross-sectional study", Lancet Neurol, 13, pp.997~1005 (2014)
42. Lee JH, "Sex-specific association of sex hormones and gonadotropins, with brain amyloid and hippocampal neurodegeneration", Neurobiol Aging, 58, pp.34~40 (2017)
43. Hayes AF, "Regression-based statistical mediation and moderation analysis in clinical research : observations, recommendations, and implementation", Behav Res Ther, 98, pp.39~57 (2017)
44. Lee DH, "Total 25-hydroxy vitamin D level in cerebrospinal fluid correlates with serum total, bioavailable, and free 25-hydroxy vitamin D levels in Korean population", PLoS One, 14, pp.e0213389~ (2019)
45. Dursun E, "A novel perspective for Alzheimer's disease : vitamin D receptor suppression by amyloid-β and preventing the amyloid-β induced alterations by vitamin D in cortical neurons", J Alzheimers Dis, 23, pp.207~219 (2011)
46. Pierucci F, "Vitamin D3 protects against Aβ peptide cytotoxicity in differentiated human neuroblastoma SH-SY5Y cells : A role for S1P1", p38MAPK, Neuropharmacology, pp.2017, 116[DOI]
47. Zelzer S, "Association of vitamin D metabolites with cognitive function and brain atrophy in elderly individuals-the Austrian stroke prevention study", Aging(Albany NY), 13, pp.9455~9467 (2021)
48. Al-Amin M, "Vitamin D deficiency is associated with reduced hippocampal volume and disrupted structural connectivity in patients with mild cognitive impairment", Hum Brain Mapp, 40, pp.394~406 (2019)
49. Karakis I, "Association of serum vitamin D with the risk of incident dementia and subclinical indices of brain aging : the Framingham Heart Study", J Alzheimers Dis, 51, pp.451~461 (2016)

관련 논문AI추천